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A 5-base deleted mutation of adenomatous polyposis coli (AK) gene was detected by using 
electrospray ionization mass spectrometry of polymerase chain reaction (PCR) products. 
Genomic DNA was extracted from a familial adenomatous polyposis patient blood, and a 
57-base pairs segment of AK gene was amplified by PCR. The PCR products were purified, 
digested with restriction endonuclease, purified, and determined by electrospray mass 
spectrometry. (J Am Sot Mass Spectrom 1997, 8, 737-742) 0 1997 American Society for 
Mass Spectrometry 
G 
enetic diagnosis has become an important area 
in medicine because it can determine whether 
one has specific gene mutations responsible for 
analysis [8], DNA sequencing [9, lo]). Most of these 
methods depend on gel electrophoresis to separate by 
size the target DNA from impurities or byproducts. 
various hereditary or sporadic diseases. A variety of By using a polyacrylamide gel electrophoresis for 
methods have been developed during the last two DNA sequencing, which has the highest resolution of 
decades to detect a mutation by using the polymerase all gel electrophoresis-based methods for DNA analy- 
chain reaction (PCR) [l] (e.g., the PCR restriction frag- sis, however, we can determine the base length of DNA, 
ment length polymorphism method (PCR-RFLP) 12, 31, but cannot distinguish one base substitution. This is the 
the PCR-allele specific oligonucleotide method (PCR- limit of resolution of the electrophoresis-based method 
ASO) [4], multiplex PCR [5], allele specific-PCR (AS- [ll-131. Furthermore, electrophoresis-based methods 
PCR) 161, the PCR-single stranded conformational poly- are laborious, time-consuming, and sometimes require 
morphism method (PCR-SSCP) [7], heteroduplex the use of radioactivity. 
Mass spectrometry formerly could not be fully ap- 
plied to the analysis of nucleic acids [14], because the 
negatively charged phosphodiester backbone is fragile 
under the usual ionization techniques and, therefore, 
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nucleic acids easily decompose into many fragments. 
Furthermore, the backbone has an affinity for nonvola- 
tile cations, especially Nat and K+ and, therefore, the 
mass peak of the nucleic acid is split into many satellite 
peaks. With recent development of more gentle ioniza- 
tion techniques such as electrospray ionization (ESI) 
[ 15-201 and matrix-assisted laser desorption ionization 
(MALDI) [21-271, it has become possible to determine 
higher molecular weight oligonucleotides (>lO,OOO Da) 
by mass spectrometry. It was also found in recent works 
that removal of nonvolatile cations is very important to 
obtain better mass spectra; replacement of sodium ion 
with ammonium ion followed by ethanol precipitation, 
use of a cation-exchange column for removal of the 
sodium ion, and the addition of triethylamine, imida- 
zole, or piperidine for adsorbing sodium ion have made 
it possible to measure 50- to lOO-mer synthetic oligonu- 
cleotides by ESI-mass spectrometry (MS) [28] or ES1 
coupled with Fourier-transform mass spectrometry 
(ESI-FIMS) [29-311. 
Usually the minimum amount of DNA necessary for 
ES1 measurements is 0.2 to 1 nmol. Because such a large 
amount of DNA is difficult to obtain directly from a 
human specimen, a large scale of PCR amplification is 
essential. Another major probIem is that the PCR prod- 
ucts have nonspecific molecular weights, because Taq 
polymerase transfers a nontemplated and unexpected 
nucleotide adduct to the 3’-end of each strand of the 
PCR products owing to its terminal deoxynucleotidyl 
transferase activity 1321. To avoid this problem, we 
designed PCR primers that included a restriction en- 
zyme EcoRI recognition site at the 5’-end [33]. This 
technique is quite common in the recombinant DNA 
method in which the target DNA produced by PCR 
with primers including restriction enzyme recognition 
site is digested, for ligating it into circular vector DNA, 
which is aIso digested with the same enzyme. The PCR 
products obtained by this strategy were purified and 
digested by EcoRI to remove the nontemplated ends. 
An alternate method to avoid the nontemplated nucle- 
otide adduct was demonstrated by using the Pfu DNA 
polymerase, which has more faithful polymerase activ- 
ity than Taq [31]. 
Here, we demonstrate that a 5-base deletion of the 
APC gene can be accurately determined by ESI-MS 
from PCR amplified human blood DNA. The APC gene 
is one of the cancer suppressor genes, and germline 
mutation in it generally causes FAP, which is an auto- 
somal dominant inherited disease, and confers a high 
risk of colon cancer [34-371 before the age of 40. This 




The sample preparation was described elsewhere [33]. 
Briefly, Genomic DNA was prepared from 1 mL of 
human whole blood J381. The first PCR was performed 
with 100 ng of genomic DNA and 1 pmol of primer ICI 
and IC2 in 100 FL solution that also contained 2.5 units 
of Taq polymerase, buffer, and deoxynucleotide 
triphosphate (dNTP) J391. A second PCR was per- 
formed in 50 microtubes, each with one-fiftieth (0.2 PL) 
of the first PCR products solution, 10 pmol each of 
primer HT17 and HT18, which included the EcoRI 
restriction enzyme recognition sites at the 5’-end [33], 
dNTP, Taq DNA polymerase, and buffer together in a 
lOO-PL solution for producing 57 bp (normal products) 
or 52 bp (5-bp deleted products) ds-DNA segments 
internally to the first PCR products. The PCR products 
were concentrated and purified by the phenol/chloro- 
form extraction and the ethanol precipitation method 
[40]. The purified products were then digested with 
2500 units of restriction enzyme EcoRI for 2 h at 37 “C. 
The digested products were purified by the phenol/ 
chloroform extraction and the ethanol precipitation 
method and redissolved into 250 PL of pure water. The 
solution was mixed with an equivalent volume (250 FL) 
of 10 M ammonium acetate for 2 h at room temperature. 
Products were then purified by the ethanol precipita- 
tion method and redissolved into 250 /IL of pure water 
again. This procedure was repeated three times. 
ES1 Measurement 
ESI-MS spectra were obtained by an HXllO/llOA dou- 
ble-focusing tandem mass spectrometer with a 2048 
channel array detector (JEOL, Tokyo, Japan). Samples 
were dissolved in aqueous 80% (v/v) acetonitrile con- 
taining 5% triethylamine at a final concentration of 1-5 
pmol/pL. 50-ILL aliquots of DNA preparations were 
introduced into the ion source at a flow rate of 2 
pL/min. The spray needle was biased at -2.5 kV. The 
voltage between the extraction cone and the first skim- 
mer element was usually set to 0 V. The source temper- 
ature was set to 70 “C. 
Results and Discussion 
To avoid the effect of terminal deoxynucleotidyl trans- 
ferase activity, the EcoRI recognition sites were in- 
cluded at the 5’-end of oligonucleotide primers (HT17, 
HTIB), and the PCR products were digested by EcoRI 
according to a strategy described previously 1331. 
Therefore, both ends of the PCR products, including the 
nontemplated nucleotide adducts, were removed, and 
the digested PCR products had a uniform base se- 
quence and molecular weight. In a previous paper [33], 
we obtained mass spectrum of 49-bp PCR products 
from the blood DNA of a normal volunteer who has no 
5-bp deletion mutation on the APC gene, showing an 
accurate measurement of the molecular masses (shown 
in Table 1). However, the thorough removal of the Taq 
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Table 1. Expected and measured masses of the PCR products with corresponding sequences 
Expected PCR products 
(Normal sense strand) 
5’-AATTCCCTGCAAATAGCAGAAATAAAAGAAAAcATTGGAACTAGGTCAG-3 ’ 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
3 ‘-GGGACGTTTATCGTCTTTATTTTCTTTTCTAACCTTGATCCAGTCTTAA-5’ 
(Normal antisense strand) 
(Deleted sense strand) 
5’-AATTCCCTGCAAATAGCAGAAATAAAAGATTGGAACTAGGTCAG-3’ 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
3’-GGGACGTTTATCGTCTTTATTTTCTAACCTTGATCCAGTCTTAA-5’ 
(Deleted antisense strand) 
Expected Measured 
mass mass 
15275.8 15,277.2 + 1.8= 
15,275.2 2 1.6b 
15,029.g 15,028.5 k 4.4a 
15.029.0 i- 1.3b 
13,693.8 13,693.2 k 2.1 
13,523.8 13,522.5 ? 2.3 
Upper and lower sequences show the normal and deleted double stranded PCR products, respectively. BValues were obtained from the normal DNA 
allele of the FAP patient. ‘Values were reported previously for the normal volunteer [331. Repetitive sequence, which was affected from the deletion, 
was indicated by underline. 
polymerase prior to the EcoRI treatment was essential 
to obtain a reasonable mass spectrum. A mass spectrum 
obtained from the EcoRl digested PCR products with- 
out thorough removal of the Taq polymerase is shown 
in Figure 1. In this case, the PCR products were con- 
centrated and purified by ethanol precipitation without 
phenol/chloroform extraction. The rest of the sample 
preparation procedure is the same as that described in 
Sample Preparation. The measured masses of 
16,508.4 + 3.5 and 16,263.l ? 3.0 Da from major peaks 
were far from expected values, 15,275.S and 15,029.8. 
Furthermore, there was another group of peaks that 
give a measured mass value of 16,841.7 t 2.0 Da. In the 















The digested products were then thought to be filled 







by the Taq polymerase, which still existed in the EcoRI 
digest. Furthermore, the filled (blunt end) products of 
nontemplated nucleotide G was added to the 3’-end of 
both strands as 
5’-AATTCCCTGCAAATAGCAGAAATAAAAGAAAAGATTG 





The former two mass values were assigned to the sense 
[16,510.6; (A)] and antisense [16,264.6; (B)] strand of the 
“blunt end” products. The remaining value was as- 
signed to a guanine adduct [16,839.8; (C)l to the sense 
strand of the “blunt end“ products. The results indicate 
that Taq polymerase is slightly active even after the 
ethanol precipitation and has the terminal deoxynucleo- 
tidy1 transferase activity [32]. If gel electrophoresis had 
been employed in the analysis, this unexpected phe- 
nomenon may have been missed. ESI-MS clearly de- 
tected this phenomenon, indicating one of the advan- 
tages of MS. 
Next, genomic DNA, which was extracted from the 
blood of a FAP family member, was examined. The 
proband of the family carried a 5-bp deletion (AAAGA) 
at codon 1,309 of AK gene, which is often observed in 
the FAP genotypes, and it was already determined that 









Figure 1. Mass spectrum of EcoRI digested PCR products without intensive removal of Taq 
polymerase. The sense and antisense strand of “blunt end” products that were derived from a filling 
up of the recessed ends of EcoRI digested PCR products with dNTPs were indicated with open and 
filled squares, respectively. An additional group of ion peaks, which was derived from a guanine 
adduct to the sense strand of the “blunt end” products, was indicated with a filled star. 
the family member carried the deletion (mutation anal- and 15,028.5 ? 4.4 Da were assigned to a sense strand of 
ysis of this family was described in detail elsewhere the deleted allele, an antisense strand of the deleted 
[391). The proband inherited the mutation from an allele, a sense strand of the normal allele and an 
affected parent, so one allele of the subject is deleted antisense strand of the normal allele, respectively (Table 
and the other is intact. The heterozygosis is consistent 1). The expected masses of each fragment are 13,693.8, 
with the mass spectrum (see Figure 2) that consists of 13,523.8, 15,275.8, and 15,029.g Da, respectively, corre- 
four major components of ion peaks. The measured sponding closely to the measured mass. The spectrum 
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Figure 2. Mass spectrum of EcoRI digested PCR products amplified from an FAP family member. The 
sense and antisense strand of the digested PCR products from normal allele was indicated by open and 
filled circles, respectively. The sense and antisense strand from the deleted allele was indicated by open 
and filled triangles, respectively. The inset shows the fine structure of ion peaks that were assigned to the 
ion fragments with 18- charge from the normal (wild type) sense strand &V’S) and normal antisense strand 
(WA), and the ion fragments with 16- charge from the deleted (mutant type) sense strand (MS) and 
deleted antisense strand (MA), respectively. See Table 1 for mass value comparison. 
J Am Sot Mass Spectrom 1997, 8, 737-742 GENETIC DIAGNOSIS BY I’CR AND ESI-MS 741 
paper 1331 serves as the control for the present study, 
and the control showed two accurate mass values 
corresponding to the sense and antisense strand of the 
normal allele. Thus, the PCR products from the healthy 
individual showed only two groups of mass peaks, 
while those from affected individual showed an addi- 
tional two groups of mass peaks corresponding accu- 
rately to the deleted mass values. The measured mass 
differences between the normal allele and the deleted 
allele of 1583.9 2 2.8 (sense strand) and 1506.0 -+ 5.0 Da 
(antisense strand) also correspond closely to the ex- 
pected masses of deleted segment of 1582.0 (AAAGA) 
and 1506.0 (TTTCT) Da, respectively. This does not 
mean that we could determine the sequence of the 
deleted part, but that we could only confirm the dele- 
tion. 
In this communication, we have clearly demon- 
strated that ESI-MS allows precise measurement of PCR 
products and accurate detection of a 5-bp deletion, 
although it does not allow us to determine the se- 
quence. The mass resolving power of ESI-MS seems to 
be sufficient to determine the difference in molecular 
weight of as low as 9 Da, which is the smallest differ- 
ence in case of one base substitution (A to T), while the 
gel electrophoresis can only detect one nucleotide 
length difference at most. Recently, Doktycz et al. and 
Chang et al. reported genetic diagnosis by time-of-flight 
mass spectrometry and MALDI [41,421, but the resolv- 
ing power of their spectra was no better than that of gel 
electrophoresis. 
Conclusion 
We demonstrated the first application of PCR-ESI-MS 
to an actual genetic diagnosis. We detected a 5-base 
deletion mutation from the blood DNA of an FAP 
patient. However, it is difficult now to replace gel 
electrophoresis with mass spectrometry in the fields of 
genetic diagnosis and other DNA analysis, because the 
sample preparation procedure is laborious and the 
instrument is far more expensive than the gel-electro- 
phoretic apparatus. However, mass spectrometry has 
many advantages including accuracy, rapidity, and 
ease of automation. In the near future, mass spectrom- 
etry will be a powerful tool for DNA analysis compa- 
rable to or superior to gel electrophoresis if the sample 
preparation is simplified and a specialized and inexpen- 
sive mass spectrometer for DNA analysis is developed. 
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